State Key Laboratory of Genetic Engineering, School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai 200438, China.
Children's Hospital of Fudan University, National Children's Medical Center, Shanghai 201102, China.
Mol Ther. 2023 Apr 5;31(4):1177-1187. doi: 10.1016/j.ymthe.2023.01.029. Epub 2023 Feb 1.
CjCas9 is one of the smallest CRISPR-associated (Cas9) nucleases for mammalian genome editing. However, it requires a long NRYAC (R = A or G; Y = C or T) protospacer-adjacent motif (PAM), limiting its DNA targeting scope. In this study, we investigated the PAMs of three CjCas9 orthologs, including Hsp1Cas9, Hsp2Cas9, and CcuCas9, by performing a GFP-activation assay. Interestingly, Hsp1Cas9 and CcuCas9 recognized unique NRAA and NCNA PAMs, respectively. We further generated an Hsp1Cas9-Hsp2Cas9 chimeric Cas9 (Hsp1-Hsp2Cas9), which recognized a simple NCY PAM. Genome-wide off-target analysis revealed that Hsp1-Hsp2Cas9 has very few off-targets compared to SpCas9. By analyzing the crystal structure of CjCas9, we identified eight mutations that can improve the specificity and generate a high-fidelity Hsp1-Hsp2Cas9-Y. Hsp1-Hsp2Cas9-Y enables the knockout of B4GALNT2 and CMAH in porcine fetal fibroblasts (PFFs). Moreover, we developed a high-fidelity Hsp1-Hsp2Cas9-KY which displayed undetectable off-targets revealed by GUIDE-seq at four tested loci. These natural and engineered Cas9 nucleases enabled efficient genome editing in multiple mammalian cells, expanding the DNA targeting scope.
CjCas9 是用于哺乳动物基因组编辑的最小的 CRISPR 相关(Cas9)核酸酶之一。然而,它需要一个长的 NRYAC(R=A 或 G;Y=C 或 T)原间隔序列邻近基序(PAM),限制了其 DNA 靶向范围。在这项研究中,我们通过 GFP 激活测定法研究了三种 CjCas9 同源物(Hsp1Cas9、Hsp2Cas9 和 CcuCas9)的 PAM。有趣的是,Hsp1Cas9 和 CcuCas9 分别识别独特的 NRAA 和 NCNA PAM。我们进一步生成了 Hsp1Cas9-Hsp2Cas9 嵌合 Cas9(Hsp1-Hsp2Cas9),它识别简单的 NCY PAM。全基因组脱靶分析显示,与 SpCas9 相比,Hsp1-Hsp2Cas9 的脱靶很少。通过分析 CjCas9 的晶体结构,我们确定了八个突变,可以提高特异性并产生高保真度的 Hsp1-Hsp2Cas9-Y。Hsp1-Hsp2Cas9-Y 能够敲除猪胎儿成纤维细胞(PFF)中的 B4GALNT2 和 CMAH。此外,我们开发了一种高保真度的 Hsp1-Hsp2Cas9-KY,在四个测试基因座,通过 GUIDE-seq 检测不到脱靶。这些天然和工程化的 Cas9 核酸酶在多种哺乳动物细胞中实现了高效的基因组编辑,扩展了 DNA 靶向范围。